Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple myeloma.

M M Oken

    The Medical Clinics of North America
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Multiple myeloma, a plasma cell cancer, causes bone destruction and organ damage. Supportive care and chemotherapy improve survival and quality of life for patients.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Interferon in the Treatment of Refractory Multiple Myeloma: An Eastern Cooperative Oncology Group Study.

    Leukemia & lymphoma·2016
    Same author

    Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC/ECOG randomized phase III study.

    Leukemia·2012
    Same author

    A phase II trial of melphalan or thioguanine in the treatment of patients with advanced renal cell cancer.

    Urologic oncology·2011
    Same author

    Clinical and biological significance of RAS mutations in multiple myeloma.

    Leukemia·2008
    Same author

    Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.

    Leukemia·2006
    Same author

    Ploidy status rarely changes in myeloma patients at disease progression.

    Leukemia research·2005
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Pathology

    Background:

    • Multiple myeloma is a plasma cell malignancy.
    • It often results in skeletal destruction, bone marrow failure, and renal dysfunction.
    • Monoclonal myeloma proteins contribute to disease complications.

    Purpose of the Study:

    • To summarize the key aspects of multiple myeloma.
    • To highlight the importance of supportive care and chemotherapy.

    Main Methods:

    • This abstract is a summary of existing knowledge.
    • No specific experimental methods were employed.

    Main Results:

    • Multiple myeloma is characterized by malignant plasma cell proliferation.
    • Skeletal destruction, bone marrow failure, and renal issues are common.
    • Monoclonal proteins are a hallmark of the disease.

    Conclusions:

    • Effective chemotherapy and vigilant supportive care are crucial.
    • These interventions can extend survival and enhance patient quality of life.